Abstract
Background:
To evaluate the long-term progression of autosomal recessive retinitis pigmentosa (RP) due to mutations in KIZ using multimodal imaging and a quantitative analytical approach.
Methods:
Whole exome sequencing (WES) and targeted capture sequencing were used to identify mutation. Fundus photography, short-wavelength autofluorescence (SW-AF), spectral-domain optical coherence tomography (SD-OCT) imaging, and electroretinography (ERG) were analyzed. Serial measurements of peripheral retinal pigment epithelium (RPE) atrophy area with SW-AF, as well as the ellipsoid zone (EZ) width using SD-OCT were performed.
Results:
Two homozygous variants in KIZ—a c.226C>T mutation as well as a previously unreported c.119_122delAACT mutation—were identified in four unrelated patients. Fundus examination and ERG revealed classic rod-cone dysfunction, and SD-OCT demonstrated outer retinal atrophy with centrally preserved EZ line. SW-AF imaging revealed hyperautofluorescent rings with surrounding parafoveal, mid-peripheral and widespread loss of autofluorescence. The RPE atrophy area increased annually by 4.9%. Mean annual exponential rates of decline for KIZ patients were 8.5% for visual acuity and 15.9% for 30 Hz Flicker amplitude. The average annual reduction distance of the EZ distance was 66.5 μm per year.
Conclusions:
RPE atrophy progresses along with a loss of photoreceptors, and parafoveal RPE hypoautofluorescence is commonly seen in KIZ-associated RP patients. KIZ-associated RP is an early-onset severe rod-cone dystrophy.
Keywords: KIZ, retinitis pigmentosa, genetic testing, disease progression, ciliopathy
Introduction
Retinitis pigmentosa (RP) is a heterogeneous category of retinal dystrophies that is characterized by the degeneration of rods followed by gradual cone death. This condition is typically attributed to mutations affecting photoreceptors or retinal pigment epithelial (RPE) cells (1,2). The most common inheritance pattern for RP is autosomal recessive (50–60% of all RP), followed by autosomal dominant (30–40%), and X-linked (5–15%) (1).
Kizuna Centrosomal Protein (KIZ; OMIM#615757) is a centrosomal substrate of Polo-like kinase-1 (PLK1) that functions by regulating mitotic chromosome stability (3). Mutations in the KIZ gene have been recently reported to cause autosomal recessive RP (arRP) in seven individuals from five unrelated families (4–6). Patients with KIZ-associated RP exhibit fundus features of typical RP, such as waxy pale optic disc, retinal vascular attenuation, and bone spicule pigmentary changes along the arcades (4,5). However, how this ciliopathy affects different cell types in the retina is unknown.
In this study, we present the clinical characteristics, genetic findings, and long-term progression of four patients with RP caused by mutations in KIZ.
Patients and methods
Approval from the Institutional Review Board (IRB) ethics committee at Columbia University was obtained before undertaking this research project (IRB#AAAB6560). Ophthalmic examination notes were retrospectively reviewed in patients. Best-corrected visual acuity (BCVA), slit-lamp biomicroscopy, fundus examination, spectral-domain optical coherence tomography (SD-OCT) scans through the fovea, and short-wavelength fundus autofluorescence (SW-AF, 488 nm), were obtained in all four affected patients with Spectralis HRA+OCT (Heidelberg Engineering, Heidelberg, Germany). Full-field electroretinogram (ERG) testing was performed according to the International Society for Clinical Electrophysiology of Vision (ISCEV) standards (7).
Genetic testing was performed in all four patients in this study, using either whole exome sequencing (WES, A-II:2, B-II:1, and D-II:5) or targeted capture sequencing of 280 retinal dystrophy-related genes (C-II:1).
The horizontal length of the intact ellipsoid zone (EZ) line in SD-OCT and the hypoautofluorescent areas representative of RPE atrophy in SW-AF were measured using ImageJ (Bethesda, MD, USA).
Snellen BCVA was converted to logMAR units for comparison. LogMAR units were used to quantify low vision, where hand motion = 2.0 (8). All analyses were performed using SPSS Statistics for Windows, version 23 (IBM, Armonk, NY, USA).
Results
This study includes four unrelated, KIZ-associated RP patients (A-II:2, B-II:1, C-II:1, and D-II:5) with a mean age of 48 ± 18.9 years (Figure 1). The homozygous variant c.226C>T was identified in individuals A-II:2, C-II:1, and D-II:5 (Figure 1). Individual B-II:1 is the first reported patient to harbor a pathogenic homozygous disruptive variant c.119_122delAACT. A summary of the affected individual genotypes is listed in Table 1.
Table 1.
ID | KIZ variant | Protein consequence | Frequency of variant in control (gnomAD) database | Prediction |
---|---|---|---|---|
| ||||
A-II:2 | c.226C>T | p.Arg76Ter | 0.0004433 | Pathogenic |
B-II:1 | c.119_122delAACT | p.Lys40llefsTer14 | 0.00003832 | Pathogenic |
C-II:1 | c.226C>T | p.Arg76Ter | 0.0004433 | Pathogenic |
D-II:5 | c.226C>T | p.Arg76Ter | 0.0004433 | Pathogenic |
The patients in this study exhibited chorioretinal phenotypes characteristic of RP (Figure 1). All patients initially presented with night blindness followed by progressive constriction of their visual field. Notably, three of the four patients (A-II:2, B-II:1, C-II:1) retained normal visual acuity from the first visit. However, the visual acuity of patient D-II:5 deteriorated to hand motion in both eyes by age 49 (Table 2), which suggests rapid photoreceptor death. The mean annual exponential rate of decline for visual acuity in the KIZ patients in this study was 8.5%.
Table 2.
ID | Age of onset, sex | Age at 1st visit | Age at last visit | VA 1st RE/LE | VA last RE/LE |
---|---|---|---|---|---|
A-II:2 | 41, M | 57 | 62 | 20/40, 20/50 | 20/30, 20/40 |
B-II:1 | 50, M | 57 | 60 | 20/30, 20/80 | 20/60, 20/400 |
C-II:1 | 20, M | 21 | 21 | 20/30, 20/25 | NA, NA |
D-II:5 | 35, M | 35 | 49 | 20/150, 20/150 | HM, HM |
Ages are indicated in years.
Abbreviations are as follows: VA = visual acuity; LE = left eye; RE = right eye; HM = hand motion; NA = not available; M = male.
In SD-OCT scans, the length of the EZ line (distance between the temporal to nasal terminations of the band) was found to decrease in three patients (A-II:2, B-II:1, and D-II:5) with disease progression (Figure 2a, Supplemental Tables 1–3). The average annual reduction distance was 66.5 μm per year. In SW-AF images, the area of RPE atrophy was found to increase with disease progression (Figure 2b), with a mean annual increase of 4.9%.
ERG recordings were collected from three patients (A-II:2, B-II:1, and D-II:5) (Figure 3). For A-II:2 at 60 years of age and D-II:5 at age 37 years of age, ERG rod responses of the right eyes were almost undetectable. The mean 30-Hz response amplitude at the first visit (18.6 μV) was reduced by 80.8% from the age-matched mean normal of 96.8 μV. The mean cone 30-Hz flicker implicit time (35.3 milliseconds) was significantly delayed from the age-matched mean normal of 29.3 milliseconds. At their most recent visits, all patients except B-II:1 (rod amplitude, 39.6 μV, OD; 43.3 μV, OS; data not shown) had undetectable rod responses. A longitudinal study of individuals A-II:2 and D-II:5 revealed that the amplitudes of the 30-Hz Flicker exhibited a downward trend, the mean annual rates of decline was 15.9%. These findings point to a severe, early-onset rod-cone dystrophy.
Discussion
The KIZ protein localizes to the outer nuclear layer of the retina, specifically the bottom of the cilia and basal body of cilium-associated centrioles (4). To date, over 30 genes have been reported to be associated with ciliopathy (RetNet: https://sph.uth.edu/retnet/), which can lead to either non-syndromic or syndromic retinal degeneration. Here, we described the clinical characteristics and disease progression of KIZ-associated RP.
The presence of EZ has been reported to be associated with better visual acuity in RP patients, and the absence of EZ may reflect a foveal dysfunction (9). In this study, the mean annual exponential rate of decline for visual acuity in the patients with KIZ mutation in this study was 8.5%. In particular, the visual acuity of patient D-II:5 significantly decreased during the past eight years, which can be attributed to macular dystrophy, indicated by the short remaining EZ line. It is worth noting that the visual acuity of the left eye of patient B-II:1 was significantly reduced, but the EZ line length did not shorten faster than his right eye. Patient B-II:1 had no other eye diseases beside RP. It is not clear whether this is related to the deletion of important domains of the KIZ by the mutation of deletion (c.119_122delAACT) in patient B-II:1 rather than the missense mutation (c.226C>T) in the other three patients. Long-term observation and further study of KIZ are needed to elucidate causative mechanisms.
The mean EZ line reduction distance was 66.5 μm per year among all the patients with KIZ mutations in this study. Although the decreased rate was smaller than that of the previously reported RP patients, the EZ line distance at the first visits was shorter than those found in published studies (10–12). This indicates that photoreceptor atrophy had developed long before the visual field loss among the patients in this study.
According to longitudinal data, all the patients with a KIZ mutation showed a significant increase in the dark adaptation threshold, which suggests that night vision loss occurred before the first visit. ERG rod response amplitudes were severely attenuated or extinguished. The mean annual rate of decline in cone 30-Hz flicker response among patients with KIZ mutations was 15.9%, which is higher than the average annual decline rate of 10% per year that was reported among RP patients (13–16).
SW-AF images showed that area of RPE atrophy increased 4.9% annually among the patients with KIZ mutations in this study. A previous study using wide-field FAF showed that the extent of abnormal FAF is related to the visual field in patients with chorioretinitis; and it was also suggested that, as in patients with RP, the location and size of the scotoma correspond spatially to the area of abnormal FAF (17). We suspect that the RPE atrophy area expansion rate can objectively reflect the visual function, and provide an estimate of RP disease progression. Notably, individual C-II:1 exhibited preserved central autofluorescence surrounded by a hyperautofluorescent ring of variable diameter at 21 years old, while the other three patients (A:II-2, B:II-1 and D:II-5), in later stages of the disease, have significantly more severe RPE atrophy concentrated in the peripheral region of the hyperautofluorecent ring, indicating severe rod damage.
Consistent with these findings, KIZ is associated with severe phenotypes. Comparing with other ciliopathy-associated arRP genes such as C2orf71, MAK and FAM161A, which are characterized by milder RP phenotypes without macular involvement or steep progression like KIZ (18–22). It is not clear why different ciliopathies have variable phenotypes; longer courses of observation and further studies are necessary to elucidate this finding.
In summary, we observed progressive, arRP without syndromic features in patients with missense or deletion mutations in KIZ. RPE atrophy appears to gradually increase along with a progressive loss of photoreceptors. Additionally, KIZ-associated RP patients are commonly associated with parafoveal RPE hypoautofluorescence, as compared to non-syndromic RP patients. KIZ-associated RP is a severe early-onset rod-cone dystrophy.
Supplementary Material
Acknowledgments
Funding
YCL is supported by the China Scholarship Council (NO.201806320164). Jonas Children’s Vision Care is supported by National Institutes of Health 5P30CA013696, R24EY027285, R01EY018213, R01EY024698, R01EY026682, R01EY024091, R21AG050437, U01EY030580, the Schneeweiss Stem Cell Fund, New York State [C029572], the Foundation Fighting Blindness New York Regional Research Center Grant [C-NY05-0705-0312], Nancy & Kobi Karp, The Rosenbaum Family Foundation, the Gebroe Family Foundation, Alcon Research Institute, the Research to Prevent Blindness (RPB) Physician-Scientist Award, unrestricted funds from RPB, New York, NY, USA.
Footnotes
Declaration of interest
The authors report no conflicts of interest. The authors alone are responsible for the content and writing of this article.
References
- 1.Hartong DT, Berson EL, Dryja TP. Retinitis pigmentosa. Lancet.2006;368:1795–809. doi: 10.1016/S0140-6736(06)69740-7. [DOI] [PubMed] [Google Scholar]
- 2.Hamel C. Retinitis pigmentosa. Orphanet J Rare Dis. 2006;1:40. doi: 10.1186/1750-1172-1-40. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Oshimori N, Ohsugi M, Yamamoto T. The Plk1 target Kizunastabilizes mitotic centrosomes to ensure spindle bipolarity. Nat Cell Biol. 2006;8:1095–101. doi: 10.1038/ncb1474. [DOI] [PubMed] [Google Scholar]
- 4.El Shamieh S, Neuille M, Terray A, Orhan E, Condroyer C,Demontant V, Michiels C, Antonio A, Boyard F, Lancelot ME, et al. Whole-exome sequencing identifies KIZ as a ciliary gene associated with autosomal-recessive rod-cone dystrophy. Am J Hum Genet. 2014;94:625–33. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Gustafson K, Duncan JL, Biswas P, Soto-Hermida A, Matsui H,Jakubosky D, Suk J, Telenti A, Frazer KA, Ayyagari R. Whole genome sequencing revealed mutations in two independent genes as the underlying cause of retinal degeneration in an Ashkenazi Jewish Pedigree. Genes (Basel). 2017;8:210. doi: 10.3390/genes8090210. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.El Shamieh S, Mejecase C, Bertelli M, Terray A, Michiels C,Condroyer C, Fouquet S, Sadoun M, Clerin E, Liu B, et al. Further insights into the ciliary gene and protein KIZ and its murine ortholog PLK1S1 mutated in rod-cone dystrophy. Genes (Basel). 2017;8:277. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.McCulloch DL, Marmor MF, Brigell MG, Hamilton R, Holder GE, Tzekov R, Bach M. ISCEV standard for full-field clinical electroretinography (2015 update). Doc Ophthalmol. 2015;130:1–12. doi: 10.1007/s10633-014-9473-7. [DOI] [PubMed] [Google Scholar]
- 8.Tibbetts MD, Shah CP, Young LH, Duker JS, Maguire JI, Morley MG. Treatment of acute retinal necrosis. Ophthalmology. 2010;117:818–24. doi: 10.1016/j.ophtha.2009.09.001. [DOI] [PubMed] [Google Scholar]
- 9.Aizawa S, Mitamura Y, Baba T, Hagiwara A, Ogata K, Yamamoto S. Correlation between visual function and photoreceptor inner/outer segment junction in patients with retinitis pigmentosa. Eye (Lond). 2009;23:304–08. doi: 10.1038/sj.eye.6703076. [DOI] [PubMed] [Google Scholar]
- 10.Sujirakul T, Lin MK, Duong J, Wei Y, Lopez-Pintado S, Tsang SH.Multimodal imaging of central retinal disease progression in a 2-year mean follow-up of retinitis pigmentosa. Am J Ophthalmol. 2015;160:786–798 e784. doi: 10.1016/j.ajo.2015.06.032. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Cabral T, Sengillo JD, Duong JK, Justus S, Boudreault K, Schuerch K, Belfort R Jr., Mahajan VB, Sparrow JR, Tsang SH Retrospective analysis of structural disease progression in retinitis pigmentosa utilizing multimodal imaging. Sci Rep. 2017;7:10347. doi: 10.1038/s41598-017-10473-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Takahashi VKL, Xu CL, Takiuti JT, Apatoff MBL, Duong JK,Mahajan VB, Tsang SH. Comparison of structural progression between ciliopathy and non-ciliopathy associated with autosomal recessive retinitis pigmentosa. Orphanet J Rare Dis. 2019;14:187. doi: 10.1186/s13023-019-1163-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Birch DG, Anderson JL, Fish GE. Yearly rates of rod and cone functional loss in retinitis pigmentosa and cone-rod dystrophy. Ophthalmology. 1999;106:258–68. doi: 10.1016/S0161-6420(99)90064-7. [DOI] [PubMed] [Google Scholar]
- 14.Berson EL. Long-term visual prognoses in patients with retinitispigmentosa: the Ludwig von Sallmann lecture. Exp Eye Res. 2007;85:7–14. doi: 10.1016/j.exer.2007.03.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Berson EL, Rosner B, Weigel-DiFranco C, Dryja TP, Sandberg MA. Disease progression in patients with dominant retinitis pigmentosa and rhodopsin mutations. Invest Ophthalmol Vis Sci. 2002;43:3027–36. [PubMed] [Google Scholar]
- 16.Mendes HF, van der Spuy J, Chapple JP, Cheetham ME. Mechanisms of cell death in rhodopsin retinitis pigmentosa: implications for therapy. Trends Mol Med. 2005;11:177–85. doi: 10.1016/j.molmed.2005.02.007. [DOI] [PubMed] [Google Scholar]
- 17.Seidensticker F, Neubauer AS, Wasfy T, Stumpf C, Thurau SR,Kampik A, Kernt M. Wide-field fundus autofluorescence corresponds to visual fields in chorioretinitis patients. Clin Ophthalmol. 2011;5:1667–71. doi: 10.2147/OPTH.S26224. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Gerth-Kahlert C, Tiwari A, Hanson JVM, Batmanabane V, Traboulsi E, Pennesi ME, Al-Qahtani AA, Lam BL, Heckenlively J, Zweifel SA, et al. C2orf71 mutations as a frequent cause of autosomal-recessive retinitis pigmentosa: clinical analysis and presentation of 8 novel mutations. Invest Ophthalmol Vis Sci. 2017;58:3840–50. [DOI] [PubMed] [Google Scholar]
- 19.Collin RW, Safieh C, Littink KW, Shalev SA, Garzozi HJ, Rizel L,Abbasi AH, Cremers FP, den Hollander AI, Klevering BJ, et al. Mutations in C2ORF71 cause autosomal-recessive retinitis pigmentosa. Am J Hum Genet. 2010;86:783–88. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.van Huet RA, Siemiatkowska AM, Ozgul RK, Yucel D, Hoyng CB, Banin E, Blumenfeld A, Rotenstreich Y, Riemslag FC, den Hollander AI, et al. Retinitis pigmentosa caused by mutations in the ciliary MAK gene is relatively mild and is not associated with apparent extra-ocular features. Acta Ophthalmol. 2015;93:83–94. [DOI] [PubMed] [Google Scholar]
- 21.Di Gioia SA, Letteboer SJ, Kostic C, Bandah-Rozenfeld D, Hetterschijt L, Sharon D, Arsenijevic Y, Roepman R, Rivolta C. FAM161A, associated with retinitis pigmentosa, is a component of the cilia-basal body complex and interacts with proteins involved in ciliopathies. Hum Mol Genet. 2012;21:5174–84. doi: 10.1093/hmg/dds368. [DOI] [PubMed] [Google Scholar]
- 22.Van Schil K, Klevering BJ, Leroy BP, Pott JW, Bandah-Rozenfeld D,Zonneveld-Vrieling MN, Sharon D, den Hollander AI, Cremers FP, De Baere E, et al. A nonsense mutation in FAM161A is a recurrent founder allele in Dutch and Belgian individuals with autosomal recessive retinitis pigmentosa. Invest Ophthalmol Vis Sci. 2015;56:7418–26. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.